Clinical trial
Study to Evaluate the Efficacy and Safety of Moxifloxacin Versus…
NCT00493038 · Bayer, Industry · Terminated
Key facts
| NCT number | NCT00493038 |
|---|---|
| Title | Study to Evaluate the Efficacy and Safety of Moxifloxacin Versus Amoxicillin/Clavulanate in the Treatment of Acute Bacterial Rhinosinusitis |
| Official title | Prospective, Multicenter, Randomized, Double Blind, Parallel Arm Study to Evaluate the Efficacy and Safety of Moxifloxacin 400 mg OD for 7 Days Versus a Standard Antibiotic Therapy for 10 Days in the Treatment of Acute Bacterial Rhino Sinusitis |
| Lead sponsor | Bayer, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Sinusitis, Bacterial Infections |
| Intervention type | Drug |
| Interventions | Moxifloxacin (Avelox, BAY12-8039), Amoxicillin/Clavulanate |
| Enrollment | 293 |
| Start date | Feb 1, 2006 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Jun 27, 2007 |
| Last update posted | Nov 7, 2014 |
| Countries | Italy |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: